Core Viewpoint - The announcement provides an update on the conversion results and share changes related to the convertible bonds issued by Shanghai Aladdin Biochemical Technology Co., Ltd, highlighting the limited conversion activity and the adjustments in conversion prices over time [2][10]. Convertible Bond Issuance Overview - The company issued 3.874 million convertible bonds with a total value of RMB 38.74 million, starting from April 12, 2022 [3]. - The initial conversion price was set at RMB 63.72 per share [4]. Conversion Status - As of June 30, 2025, a total of RMB 408,000 has been converted into 11,600 shares, representing 0.008209% of the total shares before conversion [2]. - During the period from April 1, 2025, to June 30, 2025, RMB 3,000 was converted into 185 shares, accounting for 0.000131% of the total shares before conversion [10]. - The remaining unconverted bonds amount to RMB 386,985,000, which is 99.892876% of the total issuance [2][10]. Conversion Price Adjustments - The conversion price has undergone several adjustments, with the latest being RMB 13.39 per share effective from June 5, 2025, following the implementation of the 2024 annual profit distribution plan [7][8]. - The conversion price was adjusted downwards multiple times, with the most recent adjustment from RMB 19.89 to RMB 16.17 per share effective from March 26, 2025 [8]. Redemption Status - As of December 10, 2024, the company had canceled RMB 7,000 worth of convertible bonds following a redemption request [9]. Share Capital Changes - The total share capital increased from 277,385,506 shares to 332,602,199 shares due to a capital increase plan, which involved a distribution of shares to existing shareholders [11]. Additional Information - Investors seeking detailed information about the convertible bonds can refer to the company's prospectus published on March 11, 2022 [11].
上海阿拉丁生化科技股份有限公司可转债转股结果暨股份变动公告